Drug intelligence / Profile preview

Dhara Stonil Syrup

Development stage: Unknown
Lead developer: Dhara Enterprise
Administration: Oral

Overview

Dhara Stonil Syrup is a polyherbal Ayurvedic formulation developed and manufactured by Dhara Enterprise, an Indian company specializing in herbal consumer healthcare products. The syrup is marketed as a natural remedy for the management of kidney stones (urolithiasis) and urinary tract infections. It typically contains a blend of traditional Ayurvedic herbs known for their litholytic (stone-dissolving) and diuretic properties, such as *Pashanbhed* (*Saxifraga ligulata*), *Varun* (*Crataeva nurvala*), and *Punarnava* (*Boerhavia diffusa*). As an Ayurvedic proprietary medicine, it is intended to facilitate the disintegration and expulsion of urinary calculi while providing relief from associated symptoms like pain and burning micturition.

Brand names: Dhara Stonil Syrup
Other names: Stonil Syrup

Beyond the preview

Go deeper on Dhara Stonil Syrup.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dhara Stonil Syrup.

Explore the full profile